|
|
|
|
|
1
|
Systems Biology |
Jul 2009 |
$2,345.00 |
|
A new paradigm for innovation
Growth in the pharmaceutical market has slowed - almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
2
|
Contract Rearch Annual Review 2009 |
Jun 2009 |
$545.00 |
|
The Complete Picture of the Contract Research Market
The contract research market grew by 12% last year and performed far better than the pharma market that it serves - but this year growth has stopped
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
3
|
Quality for Biologics |
Jan 2009 |
$2,325.00 |
|
Sales of biologics grew by 20% in 2007, far faster than sales of small molecule drugs, which grew by not much more than 5%. The number of biologics being launched is also growing very
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
4
|
Virtual Pharma |
Sep 2008 |
$1,495.00 |
|
Mega mergers and the blockbuster model have not delivered the benefits that were claimed for them - growth in the pharmaceutical market has slowed to no more than five per cent and the world’s
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
5
|
EvaluatePharma Yearbook |
Jul 2008 |
$2,885.00 |
|
Benchmark a Changing Market
In a fast-changing pharmaceutical market it is vital to be able to measure company performance easily and accurately - find out which companies are winning in the areas that count
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
6
|
Contract Research Annual Review 2008 |
Jun 2008 |
$545.00 |
|
Booming Contract Research Market Shows 28% Growth
Contract research grew by an extraordinary 28% last year while the pharmaceutical industry struggled with growth of around 5%, made worse by product withdrawals and adverse publicity.
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
7
|
The Rise of Mid-Sized Pharma |
May 2008 |
$1,565.00 |
|
What makes mid-sized companies successful - and what big Pharma can learn from them?
Mid-sized Pharma companies are now much more successful than their bigger rivals - they are growing faster, are more
more...
Published by: Biopharm Knowledge Publishing
|
|
|
8
|
Cardiac Toxicity |
Mar 2008 |
$2,950.00 |
|
Cardiac Toxicity - Major cause of drug withdrawal
Cardiac Toxicity has been implicated in 28% of drug withdrawals in the USA over the last 30 years - with twenty major drugs withdrawn
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
9
|
Immunogenicity to Biologics |
Oct 2007 |
$2,900.00 |
|
Immunogenicity, the body’s response to therapeutic proteins, is vitally important in the development and marketing of biotech drugs. Failure to predict and monitor levels of immunogenicity can have disastrous results for patients and for
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
10
|
Central and Core Laboratories: The Definitive Guide to the Current Status and Future Prospects of Central Clinical Pathology, ECG and Imaging Laboratories |
Oct 2007 |
$1,995.00 |
|
This report will show that the central laboratory business is today a global business worth over $1.5 billion. It is a business that is indispensable to the research based pharmaceutical industry. The report traces the
more...
Published by: Biopharm Knowledge Publishing
| Search inside this report |
|
|
11
|
Biosimilars |
Nov 2006 |
$2,160.00 |
|
Biosimilars - Evolution or Revolution?
A detailed guide to the factors that will shape this vital market, including company strategies, comparability, regulation, the implications for clinical trials and legal issues. With
more...
Published by: Biopharm Knowledge Publishing
|
|
|
|
|
|
0 items
